From contact coverage to effective coverage of community care for patients with severe mental disorders: A real-world investigation from Italy
- PMID: 36523868
- PMCID: PMC9744794
- DOI: 10.3389/fpsyt.2022.1014193
From contact coverage to effective coverage of community care for patients with severe mental disorders: A real-world investigation from Italy
Abstract
Objectives: To measure the gap between contact and effective coverage of mental healthcare (MHC).
Materials and methods: 45,761 newly referred cases of depression, schizophrenia, bipolar disorder, and personality disorder from four Italian regions were included. A variant of the self-controlled case series method was adopted to estimate the incidence rate ratio (IRR) for the relationship between exposure (i.e., use of different types of MHC such as pharmacotherapy, generic contact with the outpatient services, psychosocial intervention, and psychotherapy) and relapse (emergency hospital admissions for mental illness).
Results: 11,500 relapses occurred. Relapse risk was reduced during periods covered by (i) psychotherapy for patients with depression (IRR 0.67; 95% CI: 0.49 to 0.91) and bipolar disorder (0.64; 0.29 to 0.99); (ii) psychosocial interventions for those with depression (0.74; 0.56 to 0.98), schizophrenia (0.83; 0.68 to 0.99), and bipolar disorder (0.55; 0.36 to 0.84), (iii) pharmacotherapy for patients with schizophrenia (0.58; 0.49 to 0.69), and bipolar disorder (0.59; 0.44 to 0.78). Coverage with generic care, in absence of psychosocial/psychotherapeutic interventions, did not affect risk of relapse.
Conclusion: This study ascertained the gap between contact and effective coverage of MHC and showed that administrative data can usefully contribute to assess the effectiveness of a mental health system.
Keywords: effective coverage; health service research; healthcare utilization database; mental healthcare; quality of healthcare.
Copyright © 2022 Corrao, Monzio Compagnoni, Barbato, D’Avanzo, Di Fiandra, Ferrara, Gaddini, Saponaro, Scondotto, Tozzi, Carle, Carbone, Chisholm and Lora.
Conflict of interest statement
Author GC received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry for University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, and BMS). He also received honoraria as member of Advisory Board from Roche. Author AL was employed by ASST Lecco. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Colston J. The Use of Effective Coverage in the Evaluation of Maternal and Child Health Programs: a Technical Note for the IDB’s Social Protection and Health Division [Internet]. Washington, DC: Inter-American Development Bank; (2011).
-
- World Health Organization [WHO]. WHO Mental Health Action Plan 2013 – 2020. Geneva: World Health Organization; (2012).
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
